ArticleInfectious diseases and therapy2018

Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada".

Michele R Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.